Romiplostim as an early treatment for refractory immune thrombocytopenia in a 2‐month‐old infant
Pediatric Blood & Cancer · 2024
DOI: 10.1002/pbc.30953 ↗Kurz gefasst
Fallbericht in der Zeitschrift Pediatric Blood & Cancer, 2024. Verfasst von Yuko Chiba und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Kurashiki Central Hospital, Okayama, Japan. Hauptthemen laut MEDLINE: Purpura, Thrombocytopenic, Idiopathic, Receptors, Fc, Recombinant Fusion Proteins, Thrombopoietin. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Kurashiki Central Hospital, Okayama, Japan.
- Department of Pediatrics, Kobe City Nishi-Kobe Medical Center, Kobe, Japan.
- Department of Hematology/Oncology, Saitama Children's Medical Center, Saitama, Japan.
- Department of Pediatrics, Fukuyama City Hospital, Hiroshima, Japan.
ORCID-Profile: Keiji Tasaka
Zitieren
APA
Chiba, Y., Tasaka, K., Matsubara, K., Mori, M., Muraoka, M., Hamabata, T., Nodomi, S., & Waki, K. (2024). Romiplostim as an early treatment for refractory immune thrombocytopenia in a 2‐month‐old infant. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.30953
Vancouver
Chiba Y, Tasaka K, Matsubara K, Mori M, Muraoka M, Hamabata T, et al. Romiplostim as an early treatment for refractory immune thrombocytopenia in a 2‐month‐old infant. Pediatric Blood & Cancer. 2024. doi:10.1002/pbc.30953
BibTeX
@article{Chiba2024,
author = {Chiba, Yuko and Tasaka, Keiji and Matsubara, Kousaku and Mori, Makiko and Muraoka, Michiko and Hamabata, Takayuki and Nodomi, Seishiro and Waki, Kenji},
title = {Romiplostim as an early treatment for refractory immune thrombocytopenia in a 2‐month‐old infant},
journal = {Pediatric Blood & Cancer},
year = {2024},
doi = {10.1002/pbc.30953}
}
EUVIMED